Published in Women's Health Weekly, April 4th, 2002
This is the first time that a bisphosphonate, given at intervals of up to 1 year between doses, has produced sustained suppression of bone turnover and an increase in bone mineral density in the spine and hip as great as that seen with oral daily or weekly dosing of other bisphosphonates.
"Oral bisphosphonates, although effective in treating osteoporosis, have complicated dosing requirements that can lead to compliance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly